CanadaPMS-BUSULFAN 6 mg/mL intravenous solution (Busulfan 6mg/mL), Market Authorization DIN 02477343, lots 660609, 662713 and 656088, sold nationally, is affected. It was recalled because the content of an impurity could be out of specification before the expiry date; verify if your product is affected, consult your healthcare provider prior to discontinuing use, contact Pharmascience Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Wholesalers
Companies: Pharmascience Inc., 6111 avenue Royalmount, suite 100, Montréal, QC, H4P 2T4.
How to identify it
Product Name: PMS-BUSULFAN; Market Authorization: DIN 02477343; Dosage Form: Intravenous Solution; Strength: Busulfan 6mg/mL; Lot numbers: 660609, 662713 & 656088
The hazard
The content of an impurity could be out of specification before the expiry date in the affected lots.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)